2.2. Mouse Model of DDC-Induced Sclerosing Cholangitis

FD Fiorella D’Onofrio
GR Giorgia Renga
MP Matteo Puccetti
MP Marilena Pariano
MB Marina Maria Bellet
IS Ilaria Santarelli
CS Claudia Stincardini
PM Paolo Mosci
MR Maurizio Ricci
SG Stefano Giovagnoli
CC Claudio Costantini
LR Luigina Romani
request Request a Protocol
ask Ask a question
Favorite

For the murine sclerosing cholangitis model, the mice were given a 0.1% DDC-supplemented diet (Mucedola Srl, Milan, Italy) for 14 days (active phase). After the DDC diet, the mice were given normal chow and drinking water for the successive 14 days (recovery phase) [23]. The mice were randomly divided into 3 groups. Each group was housed in the same cage, fed and treated as follows: (a) the vehicle group was fed a control chow diet with oral gavage of distilled water, (b) the 0.1% DDC group, (c) the 0.1% DDC group treated with 18 mg/kg of 3-IAld every other day. The mice were euthanized at different time points.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A